dalteparin has been researched along with Thrombocythemia in 8 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Skin necrosis is a rare complication in intensive care unit." | 1.34 | [Nadroparin-induced skin necrosis then thrombocytosis in intensive care unit: difficulty in diagnosis]. ( Denninger, MH; Mantz, J; Paugam-Burtz, C; Perbet, S; Trouiller, P, 2007) |
| "Thrombocytosis is a further reason to monitor platelet counts during heparin treatment." | 1.33 | [Thrombocytosis: adverse effect of heparin treatment]. ( Camou, F; Caubet, O; Pellegrin, JL; Viallard, JF, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Perbet, S | 1 |
| Trouiller, P | 1 |
| Paugam-Burtz, C | 1 |
| Denninger, MH | 1 |
| Mantz, J | 1 |
| Meenpidiyil, SS | 1 |
| Azeez, S | 1 |
| Kumar, VP | 1 |
| Suresh, D | 1 |
| Kalathathoduuill, S | 1 |
| Thandupara, S | 1 |
| Puthukudi, MH | 1 |
| Tonbul, A | 1 |
| Uras, N | 1 |
| Tayman, C | 1 |
| Halici, T | 1 |
| Polat, A | 1 |
| Mansur Tatli, M | 1 |
| Camou, F | 1 |
| Viallard, JF | 1 |
| Caubet, O | 1 |
| Pellegrin, JL | 1 |
| Hummel, MC | 1 |
| Morse, BC | 1 |
| Hayes, LE | 1 |
| Rizzieri, DA | 1 |
| Wong, WM | 1 |
| Gockerman, JP | 1 |
| Williams, E | 1 |
| Ziaja, K | 1 |
| Simka, M | 1 |
| Krupowies, A | 1 |
| Dugaj, M | 1 |
| Ludyga, T | 1 |
1 trial available for dalteparin and Thrombocythemia
| Article | Year |
|---|---|
Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism.
Topics: Adolescent; Adult; Anticoagulants; Enoxaparin; Humans; Middle Aged; Orthopedic Procedures; Platelet | 1999 |
7 other studies available for dalteparin and Thrombocythemia
| Article | Year |
|---|---|
[Nadroparin-induced skin necrosis then thrombocytosis in intensive care unit: difficulty in diagnosis].
Topics: Adult; Anticoagulants; Humans; Intensive Care Units; Male; Nadroparin; Necrosis; Skin; Thrombocytosi | 2007 |
Enoxaparin induced reactive thrombocytosis: a rare adverse drug reaction.
Topics: Acute Coronary Syndrome; Anticoagulants; Enoxaparin; Female; Humans; Injections, Subcutaneous; Middl | 2020 |
Thrombocytosis associated with enoxaparin: A very rare cause in newborns.
Topics: Adolescent; Adult; Anticoagulants; Enoxaparin; Female; Humans; Infant, Newborn; Infant, Newborn, Dis | 2010 |
[Thrombocytosis: adverse effect of heparin treatment].
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Enoxaparin; Female; Fibrinolyt | 2006 |
Reactive thrombocytosis associated with enoxaparin.
Topics: Accidents; Adult; Enoxaparin; Humans; Male; Thrombocytosis; Venous Thrombosis | 2006 |
Thrombocytosis associated with low-molecular-weight heparin.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Humans; Thrombocytosis | 1996 |
Thrombocytosis associated with low-molecular-weight heparin.
Topics: Anticoagulants; Enoxaparin; Humans; Thrombocytosis | 1997 |